Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"
25-03-30 JS Investment Fund cancelled the acquisition of 37.42% stake in Curable. Inc. from GW Vitek CO.,LTD.. CI
24-11-24 JS Investment Fund signed a letter of intent to acquire 37.42% stake in Curable. Inc. from GW Vitek CO.,LTD. for KRW 5.5 billion. CI
23-01-19 Curable. Inc. agreed to acquire 8.5% stake in Pharma Biotech Korea Co., Ltd from Pharma Biotech Korea for KRW 8.5 billion. CI
23-01-18 Curable. Inc. announced that it has received KRW 5.0009986 billion in funding from GW Vitek CO.,LTD. CI
22-05-22 SNP Genetics Inc. announced that it has received KRW 10 billion in funding from Kalis BNT Co., Ltd. CI
22-05-18 Curable. Inc. announced that it expects to receive KRW 9.999995 billion in funding from GW Vitek CO.,LTD. CI
22-05-15 SNP Genetics Inc. announced that it expects to receive KRW 10 billion in funding from Kalis BNT Co., Ltd. CI
22-04-18 An unknown buyer agreed to acquire 16.82% of stake in SNP Genetics Inc. from Jo, Jin-hwan and others for KRW 3.7 billion. CI
22-04-13 SNP Genetics Inc. announced that it has received KRW 2.49999872 billion in funding CI
22-04-05 SNP Genetics Inc. announced that it expects to receive KRW 2 billion in funding CI
22-04-05 SNP Genetics Inc. announced that it expects to receive KRW 2.49999872 billion in funding CI
22-02-20 GW Vitek CO.,LTD. agreed to acquire a 40.7% stake in SNP Genetics Inc. from Hyoung-doo Shin and Myung-cheol Kim for KRW 9.4 billion. CI
21-02-05 Tranche Update on SNP Genetics Inc.'s Equity Buyback Plan announced on November 2, 2020. CI
Manager TitleAgeSince
Chief Executive Officer 61 2025-04-28
Chief Executive Officer 57 2023-04-30
Comptroller/Controller/Auditor 52 -
Director TitleAgeSince
Director/Board Member 56 -
Director/Board Member 54 -
Director/Board Member 55 -
Change 5-day change 1-year change 3-year change Capi.($)
-17.54%-84.18% - - 4.64K
-0.19%-2.87%+79.01%+75.36% 3.78B
-6.03%+4.14%+70.54%+100.46% 2.82B
+4.05%-2.03%-31.58%-39.75% 1.94B
+3.03%-3.55%+82.14%-53.85% 1.82B
-2.92%+3.24%+23.56%+174.76% 1.19B
-0.36%-6.03%-13.29%+15.43% 853M
-0.72%-22.50%+92.46% - 782M
-4.41%-0.80%+133.80%-65.98% 735M
+0.66%-4.95%-28.20%-15.87% 540M
Average -2.44%-1.15%+45.38%+23.82% 1.61B
Weighted average by Cap. -0.80%-0.54%+52.41%+40.66%
Logo Curable. Inc.
Curable Inc, SNP Genetics Inc, is a Korea-based company mainly engaged in the analysis of genomes. The company is involved in the research and development of disease-related single nucleotide polymorphism (SNP) contents using SNP. These diseases include asthma, diabetes, osteoporosis, alcoholism, tuberculosis, cancer, multiple sclerosis, obesity, mental illness, metabolic disease, lupus disease. The Company is involved in the production and sale of Kobreed kits, as well as the provision of SNP Care. The Kobreed kits are medicine for discriminating Korean beef and imported meat. SNP Care is a gene analysis service. In addition, the Company is engaged in leasing of the places of business. The major customers include government agencies such as the Disease Control Headquarters and the Food and Drug Administration.
Employees
-
  1. Stock Market
  2. Stocks
  3. A086460 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!